Company news

Bayer AG news in 2025

Bayer AG's news releases, calls and decks from 2025, newest first.

View company

Introducing Sivanto Energy: Enhanced Flea Beetle Control

December 16, 2025

Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome

December 4, 2025

RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints

December 3, 2025

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia

December 2, 2025

Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease Control

December 2, 2025

Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review

December 1, 2025

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

December 1, 2025

Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention

November 23, 2025

TetraScience and Bayer Expand Partnership to Advance Scientific Data Management

November 20, 2025

Bayer Launches "Science Delivers" Campaign Celebrating the Transformative Power of Science

November 10, 2025

Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG

November 6, 2025

KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease

November 6, 2025

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

October 31, 2025

Bayer and Luke Bryan Mark 10 Years of Fighting Hunger with YourUpdateTV

October 29, 2025

Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause

October 24, 2025

Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025

October 21, 2025

WHO Foundation and Bayer Collaborate to Support Global Health Initiatives

October 14, 2025

Vividion Announces Publication in Science of Preclinical Data on Covalent Inhibitors of RAS-PI3K that Block Tumor Growth

October 9, 2025

Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest

October 7, 2025

One A Day® Unveils Bold New Brand Identity and Platform: "The ONE for you"

October 7, 2025

Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV

October 3, 2025

AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting

October 2, 2025

Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division

September 29, 2025

Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada

September 25, 2025

Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025

September 25, 2025

Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease

September 22, 2025

AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)

September 17, 2025

10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with "Take Care, Now" Campaign

September 15, 2025

Tata Elxsi Launches a Global Technology Centre for Medical Devices from Bayer in Radiology

September 10, 2025

Bayer Foundation Backs 15 Women Entrepreneurs Scaling Urgent Healthcare and Food Solutions

September 9, 2025

Gadoquatrane New Drug Application Accepted for Review by U.S. FDA

August 27, 2025

Health Canada grants marketing authorization for an additional indication of Bayer's NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC)

August 21, 2025

Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program

August 21, 2025

Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center

August 18, 2025

Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market

August 15, 2025

Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer

August 13, 2025

Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology

August 12, 2025

K36 Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for KTX-2001 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Announces Clinical Trial Collaboration with Bayer for Supply of Darolutamide

August 7, 2025

Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause

July 25, 2025

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

July 21, 2025

DKSH and Bayer Launch Strategic Partnership Across Multiple Markets in Southeast Asia

July 9, 2025

Bayer Appoints Priyal Patel as Chief Financial Officer for North America

July 1, 2025

U.S. Supreme Court Asks for Views of Solicitor General in Durnell Case

June 30, 2025

EY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards Program

June 25, 2025

Bayer Files for Approval of gadoquatrane in the U.S.

June 17, 2025

Calls in 2025

Decks in 2025